51
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2036270
Cellipsea is a drug discovery company
- Fabrice Paublant: CEO & Co-founderPast Role: Mensia Technologies, Co-Founder and CEO
- Renaud Prudent: COO & Co-Founder
About the Company
ELLIPSE was incorporated in early 2013 by its three co-founders Dr Laurence Lafanechère, Dr Renaud Prudent and Fabrice Paublant to take the LIMINIB program from pre-clinical proof-of-concept to a first-in-class LIM Kinase inhibitor.CELLIPSE and Institut Albert Bonniot (), Grenoble won the 2013 Preuve de Concept Contest from Cancéropole CLARA
().Leveraging internal know-how in high content phenotypic screening and in small molecule lead optimization, CELLIPSE co-founders are building a leading Biotech company in the field of small molecule agents regulating the cytoskeleton with application in oncology and beyond (Central Nervous System, Ophtalmology…).
